Jon Snodgres - Aug 16, 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Financial Officer
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Aug 16, 2022
Transactions value $
-$1,222,229
Form type
4
Date filed
8/17/2022, 04:41 PM
Previous filing
Aug 2, 2022
Next filing
Oct 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $262K +3.05K +8.19% $86.10 40.2K Aug 16, 2022 Direct
transaction RGEN Common Stock Options Exercise $209K +970 +2.41% $215.58 41.2K Aug 16, 2022 Direct
transaction RGEN Common Stock Sale -$1.09M -4.3K -10.43% $252.70 36.9K Aug 16, 2022 Direct F1
transaction RGEN Common Stock Sale -$608K -2.4K -6.5% $253.16 34.5K Aug 16, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +3.05K $0.00 1.52K Aug 16, 2022 Common Stock 3.05K $86.10 Direct F2
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +970 +100% $0.00 1.94K Aug 16, 2022 Common Stock 970 $215.58 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $252.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.16 to $253.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 1,524 shares vest and become exercisable on 2/27/2023.
F3 Shares vest and become exercisable as follows: 970 shares on 2/24/2023 and 970 shares on 2/24/2024.